<DOC>
	<DOCNO>NCT02865915</DOCNO>
	<brief_summary>This Phase 2b double-blind , randomize , parallel-group , placebo-controlled study MLE4901 versus placebo woman PCOS .</brief_summary>
	<brief_title>MLE4901 v . Placebo Treatment PCOS</brief_title>
	<detailed_description>Following Screening/Wash-out Period 12 week , 8-week Lead-in Period ( start progestin challenge ) use good characterize study population . A Treatment Period 28 week ' duration follow Lead-in Period . Then , 8-week Follow-up Period ( i.e. , study drug ) use assess durability effect MLE4901 . The study duration approximately 48 week ( 11 month ) per subject</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>1 . Oligo/amenorrhea 2 . At least one follow Screening : Clinical sign hyperandrogenism , clinical hyperandrogenism may include hirsutism ( defined excessive terminal hair appear male pattern ) , acne , androgenic alopecia Biochemical hyperandrogenism refers elevate serum androgen level ( i.e. , total , bioavailable free testosterone level â‰¥ULN ) Polycystic ovarian morphology , define presence 12 follicle 29 mm diameter and/or increase ovarian volume &gt; 10 mL ( without cyst dominant follicle ) either ovary 3 . Body mass index ( BMI ) 22 45 kg/m2 , inclusive 4 . Must willing avoid use hair removal procedure product study participation 5 . Must willing avoid prescription treatment acne increase dose frequency current nonprescription acne treatment regimen study participation 6 . Must willing avoid use hair growth procedure product study participation 7 . Permanently surgically sterilize ( bilateral salpingectomy tubal occlusion ) &gt; 2 year male partner ( ) vasectomy &gt; 2 year must consent use two permit medicallyacceptable method contraception throughout study sexual intercourse male partner . Permitted medicallyacceptable method birth control study define use male condom plus one following : spermicide , diaphragm spermicide , intrauterine device contain steroid hormone . 1 . Menopausal perimenopausal , define study FSH ( follicle stimulate hormone ) &gt; 10 IU/L 2 . Irregular vaginal/menstrual bleeding cause condition PCOS ( e.g. , uterine polyp submucosal uterine fibroid ) 3 . Abnormal Papanicolaou ( Pap ) test Screening require followup sooner 1 year test 4 . Uncontrolled hypo hyperthyroidism 5 . Posthysterectomy endometrial ablation 6 . Postoophorectomy ( unilateral bilateral ) ovarian surgery 7 . Medical history type 1 type 2 diabetes mellitus</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Acne</keyword>
	<keyword>Hirsutism</keyword>
	<keyword>Menstrual Irregularity</keyword>
	<keyword>Alopecia</keyword>
</DOC>